During the past decade, Health Pharma Professional Research conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 9 clinical trials were completed, i.e. on average, 20.5% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 8 clinical trials were completed. i.e. 29.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Health Pharma Professional Research" #1 sponsor was "Hoffmann-La Roche" with 23 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored, "Shire" with 3 trials sponsored and "Amgen" with 3 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Health Pharma Professional Research" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Health Pharma Professional Research" are "Carcinoma, Non-Small-Cell Lung" (7 trials), "Non-Small Cell Lung Cancer" (4 trials), "Crohn's Disease" (3 trials), "Breast Cancer" (2 trials) and "Early Breast Cancer" (2 trials). Many other conditions were trialed in "Health Pharma Professional Research" in a lesser frequency.

Most popular intervention types in "Health Pharma Professional Research" are "Drug" (43 trials), "Biological" (2 trials), "Other" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Atezolizumab" (11 trials), "Carboplatin" (11 trials), "Gemcitabine" (7 trials) and "Paclitaxel" (7 trials). Other intervention names were less common.

The vast majority of trials in "Health Pharma Professional Research" are 43 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Health Pharma Professional Research". undefined are not yet recruiting, 21 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Health Pharma Professional Research, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Health Pharma Professional Research, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".